These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32407604)

  • 1. Retracted: Silencing of Exosomal miR-296-5p Derived from Endothelial Progenitor Cells Enhances Thrombolysis and Recanalization in Deep Vein Thrombosis.
    Clin Transl Sci; 2021 Sep; 14(5):2065-2074. PubMed ID: 32407604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction Statement: Wang, J., Yang, Z., Liu, S., Zhang, L., & Zhao, Y. Silencing of Exosomal miR-296-5p Derived from Endothelial Progenitor Cells Enhances Thrombolysis and Recanalization in Deep Vein Thrombosis, Clin. Trans. Sci. https://ascpt.onlinelibrary.wiley.com/doi/full/10.1111/cts.12799.
    Clin Transl Sci; 2022 Feb; 15(2):577. PubMed ID: 35156319
    [No Abstract]   [Full Text] [Related]  

  • 3. Retracted: MicroRNA let-7b Inhibits Proliferation and Induces Apoptosis of Castration-Resistant Prostate Cancer Cells by Blocking the Ras/Rho Signaling Pathway via NRAS.
    Clin Transl Sci; 2021 Sep; 14(5):2055-2064. PubMed ID: 32043299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.
    FEBS Open Bio; 2023 Aug; 13(8):1540. PubMed ID: 37410095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction.
    J Cell Biochem; 2021 Nov; 122 Suppl 1():S90. PubMed ID: 34191358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction.
    J Cell Biochem; 2021 Apr; 122(3-4):485. PubMed ID: 33590515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction.
    J Cell Biochem; 2021 Jul; 122(7):771. PubMed ID: 33988266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction.
    J Cell Biochem; 2021 Jan; 122(1):149. PubMed ID: 33253505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction.
    Cancer Med; 2023 May; 12(9):11041. PubMed ID: 37050853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction.
    J Cell Biochem; 2021 Jan; 122(1):146. PubMed ID: 33253502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction.
    J Cell Biochem; 2021 Nov; 122 Suppl 1():S136. PubMed ID: 34383338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RETRACTION: MeCP2 Drives Hepatocellular Carcinoma Progression Via Enforcing HOXD3 Promoter Methylation and Expression Through the HB-EGF/EGFR Pathway.
    Mol Oncol; 2024 Aug; 18(8):2061. PubMed ID: 38837853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction: LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging.
    J Cell Mol Med; 2024 Aug; 28(15):e18563. PubMed ID: 39087601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction.
    J Cell Biochem; 2021 Nov; 122 Suppl 1():S59. PubMed ID: 34191298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
    Asia Pac J Clin Oncol; 2023 Dec; 19(6):762. PubMed ID: 37888963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction.
    J Cell Biochem; 2021 Nov; 122 Suppl 1():S65. PubMed ID: 34191326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction.
    J Cell Biochem; 2021 Nov; 122 Suppl 1():S19. PubMed ID: 34107071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction.
    J Cell Biochem; 2021 Nov; 122 Suppl 1():S80. PubMed ID: 34191353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction.
    J Cell Biochem; 2021 Dec; 122(12):1974. PubMed ID: 34859892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction statement: Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
    Mol Oncol; 2023 Aug; 17(8):1692. PubMed ID: 37471281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.